Fingerprint
Dive into the research topics of 'Dual antagonist of cIAP/XIAP ASTX660 sensitizes HPV- and HPV+ head and neck cancers to TNFα, TRAIL, and radiation therapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Dual antagonist of cIAP/XIAP ASTX660 sensitizes HPV- and HPV+ head and neck cancers to TNFα, TRAIL, and radiation therapy
Roy Xiao, Yi An, Wenda Ye, Adeeb Derakhshan, Hui Cheng, Xinping Yang, Clint Allen, Zhong Chen, Nicole C. Schmitt, Carter Van Waes
Research output: Contribution to journal › Article › peer-review
8
Scopus
citations